Overview
pathway The mTOR (mammalian/mechanistic target of rapamycin) signaling pathway is a major enzyme involved in cell growth, proliferation and metabolism. It plays a crucial role in the regulation of a wide range of cellular processes such as cell cycle progression, protein synthesis and metabolism. In addition, it has been implicated in a number of human diseases, including cancer, metabolic and neurodegenerative disorders. Therefore, research into this pathway is important in order to understand and explore potential therapeutic interventions. In recent years, there has been a lot of progress in the modulating of mTOR signaling by drugs, natural products and genetic engineering. These advances have made mTOR pathway inhibitors one of the most promising drug targets for the treatment of various diseases.
Research published in this journal
5 peer-reviewed articles, ranked by relevance. Each links to its DOI.
How this research is being cited
The 5 articles above have been cited 11 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.
-
Adriana Ferreira et al. · 2024 · International Journal of Molecular Sciences
-
2024 · International Journal of Molecular Sciences
-
Jaekwon Seok et al. · 2023 · Journal of Translational Medicine
-
Iman Ehsan et al. · 2022 · Journal of Drug Delivery Science and Technology
-
2019 · Journal of Experimental and Clinical Toxicology
-
2017 · Journal of Depression And Therapy
-
2016 · Journal of Behavior Therapy And Mental Health
-
2014 · Cell Research
A sample of recent works citing this journal's research on Mtor Signaling, linking to each citing work.